Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial respiratory chain enzymes are a group of membrane-bound proteins that catalyze electron transfer through the bacterial electron transport chain, ultimately generating a proton motive force and driving ATP synthesis via ATP synthase. Key enzymes include NADH dehydrogenases (Complex I, NDH-1, NDH-2), cytochrome bc1 complex, cytochrome bd oxidase, quinone oxidoreductases, and ATP synthase. These enzymes are essential for cellular energy metabolism, viability, and pathogenesis in bacteria. Many respiratory chain enzymes are validated therapeutic targets for antibiotic and antitubercular drug development due to their indispensable role in bacterial survival—examples include ATP synthase inhibitors (bedaquiline), cytochrome bc1 inhibitors (Q203), and NDH-2 modulators (clofazimine, phenothiazines). Selective inhibition of these enzymes can lead to rapid bacterial killing while minimizing host toxicity, but concerns about resistance and specificity remain. Both the structure and mechanism of these complexes are well-characterized and have inspired ongoing efforts in antibiotic discovery.
Inhibition of ATP synthase (prevents ATP production, disrupts cell metabolism); Inhibition of cytochrome bc1 complex (QcrB) or bd oxidase (prevents electron flow, collapses proton gradient, induces cell death); Modulation/inhibition of NADH dehydrogenase (disrupts redox balance); Redox cycling leading to enhanced bacterial killing
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial respiratory chain enzyme (None established; individual enzymes may have abbreviations (e.g., NDH-2, QcrB, ATP synthase).).